Go
View All
Overall Survival in oral Cancer patients after adjustment of stage groups (MSKCC-PMH Data)
Overall survival in patients with PHs and SPGs
Overall Survival in squamous cell carcinoma of the head and neck based on the 8thEdition N criteria that incorporate ENE as a prognostic factor
Oxaliplatin
Paclitaxel
Pancreatic neuroendocrine tumors
Paracaval lymph nodes
Paragangliomas (PGs)
Paranasal sinuses and nasal cavity
Parasympathetic paragangliomas (PPGs)
Parathyroid carcinoma
Partial thromboplastin time (PTT)
Pathological criteria
Pathological criteria identifying multifocal ground-glass/lepidic lung adenocarcinoma
Pathological criteria to categorize a lesion as a separate tumor nodule (intrapulmonary metastasis)
Pathological stage (pTNM) and overall survival in gastric cancer patients who underwent surgical resection with adequate lymphadenectomy (D2) without prior chemotherapy or radiation therapy, stratified by pathological stage groupings, based on IGCA data (2000-2004; only patients with complete 5-year follow-up were included, n = 25,411)
Pathological stage and 1-, 3-, and 5-year and median overall survivals in patients with gastric cancer who received curative surgery, stratified by pathological stage groupings, based on IGCA data
Patient health questionnaire (PHQ-9)
PCR
Pelvic segments for staging
Penile Urethra
Peptic ulcer disease (PUD)
Perihilar Bile Ducts
Displaying items 691 - 720 of 1074